AMEX:XBI is giving long term buy signals as the chart displays. Super trend signals a buy, also MACD and KST crossovers confirm trend direction.
XBI is a somewhat volatile bio-tech ETF.
This ETF is also great for selling options on when volatility is high, as the premium you receive is often much higher than employing the strategy on SPY.
Here are the most current Top 10 holdings:
1 CYTK Cytokinetics, Incorporated 2.79% 2,308,666
2 KRTX Karuna Therapeutics, Inc. 1.80% 383,056
3 ARWR Arrowhead Pharmaceuticals, Inc. 1.61% 3,201,386
4 BHVN Biohaven Pharmaceutical Holding Company Ltd. 1.57% 2,381,294
5 SRPT Sarepta Therapeutics, Inc. 1.56% 904,544
6 ACAD ACADIA Pharmaceuticals Inc. 1.53% 3,752,269
Great entry. There is still much more room to run here. I think it's wise to stay invested in Healthcare and Bio-techs because artificial intelligence and it's applications should develop this industry into something very special and valuable. We live in a time where these companies will undoubtedly find a cure for most cancers and other fatal diseases. The hurdles still remain where they've always been, testing and approvals. These Bio-techs can be very sensitive to political changes but as a whole I think the ETF will outperform this coming year and the next.